Blockchain technology in healthcare market Professional Survey Report by 2035
Roots Analysis has done a detailed report on Blockchain Technology in Healthcare Industry (Focus on Drug Discovery and Clinical Trials Market), covering key aspects of the industry and identifying key future growth opportunities.
Key Market Insights
Presently, more than 50 players claim to provide blockchain platform solutions across a wide range of drug development applications
The current market landscape features stakeholders offering blockchain technology to industries for various drug development applications; majority of these technology platforms are being used for clinical trial management
The growing interest is also prevalent from the recent rise in partnership activity; ~60% of the deals, so far, have been focused on utilization and integration of proprietary blockchain platforms
Around 37% of the articles focused on the use of blockchain technology in the pharmaceutical industry have been published in the year 2022, highlighting the substantial efforts undertaken by researchers
The market is expected to witness an annualized growth of 22% in the coming decade; the opportunity is likely to be well distributed across various types of blockchain, types of end-users and key geographical regions
Request a free sample of the report
https://www.rootsanalysis.com/....reports/blockchain-t Table of Contents
1. PREFACE
1.1. Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4 Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
2.1 Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Blockchain
3.2.1. Ethereum vs Hyperledger Fabric
3.3. Types of Blockchain Technology
3.3.1. Permissionless or Public Blockchain
3.3.2. Permissioned or Private Blockchain
3.3.3. Federated or Consortium Blockchain
3.4. Applications of Blockchain Across Various Industries
3.5. Applications of Blockchain in Drug Discovery and Clinical Trials
3.6. Advantages and Limitations of Blockchain
3.7. Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. List of Blockchain Technology Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Year of Establishment, Company Size, and Region of Headquarters
4.2.6. Analysis by Type of Blockchain(s)
4.2.7. Analysis by Type of Drug Development Application(s)
4.2.8. Analysis by Application(s) within Clinical Trial Management
4.2.9. Analysis by Type of End-User(s)
4.2.10. Analysis by Type of Blockchain and Type of End-User(s)
4.2.11. Analysis by Type of Blockchain and Type of Drug Development Application(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Blockchain Technology Providers in North America (Peer Group I)
5.5. Company Competitiveness Analysis: Blockchain Technology Providers in Europe (Peer Group II)
5.6. Company Competitiveness Analysis: Blockchain Technology Providers in Asia Pacific and RoW (Peer Group III)
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Alten Calsoft Labs
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Application Areas of Proprietary Platform
6.2.4. Recent Developments and Future Outlook
6.3. ConsenSys
6.3.1. Company Overview
6.3.2. Application Areas of Proprietary Platform
6.3.3. Recent Developments and Future Outlook
6.4. IBM
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Application Areas of Proprietary Platform
6.4.4. Recent Development and Future Outlooks
6.5. Stratumn
6.5.1. Company Overview
6.5.2. Application Areas of Proprietary Platform
6.5.3. Recent Development and Future Outlook
6.6. Infosys
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Application Areas of Proprietary Platform
6.6.4. Recent Developments and Future Outlook
6.7. Tech Mahindra
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Application Areas of Proprietary Platform
6.7.4. Recent Developments and Future Outlook
6.8. Humanscape
6.8.1. Company Overview
6.8.2. Application Areas of Proprietary Platform
6.8.3. Recent Developments and Future Outlook
6.9. Hyperledger Foundation
6.9.1. Company Overview
6.9.2. Application Areas of Proprietary Platform
6.9.3. Recent Developments and Future Outlook
6.10. Innoplexus
6.10.1. Company Overview
6.10.2. Application Areas of Proprietary Platform
6.10.3. Recent Developments and Future Outlook
6.11. Medsphere
6.11.1. Company Overview
6.11.2. Application Areas of Proprietary Platform
6.11.3. Recent Developments and Future Outlook
6.12. Solulab
6.12.1. Company Overview
6.12.2. Application Areas of Proprietary Platform
6.12.3. Recent Developments and Future Outlook
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3 Blockchain in Drug Discovery and Clinical Trials: Recent Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Company Size and Type of Partnership
7.3.5. Most Active Players: Distribution by Number of Partnerships
7.3.6. Most Active Players: Distribution by Type of Partnership
7.3.7. Analysis by Type of Pharmaceutical Applications
7.3.8. Analysis by Type of Partner
7.3.9. Analysis by Geographical Region
7.3.9.1. Local and International Agreements
7.3.9.2. Intercontinental and Intracontinental Agreements
8. PUBLICATION ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Blockchain Technology in Pharmaceutical Industry: Recent Publications
8.3.1. Analysis by Year of Publication
8.3.2. Analysis by Type of Article
8.3.3. Popular Journals: Analysis by Number of Publications
8.3.4. Popular Publishers: Analysis by Number of Publications
8.3.5. Popular Copyright Holders: Analysis by Number of Publications
8.3.6. Analysis by Popular Keywords
8.3.7. Analysis by Impact Factor
8.3.8. Popular Journals: Analysis by Journal Impact Factor
9. SWOT ANALYSIS
9.1. Chapter Overview
9.2. Blockchain in Drug Discovery and Clinical Trials: SWOT Analysis
9.3. Comparison of SWOT Factors
9.3.1. Strengths
9.3.1.1. Transparency and Traceability
9.3.1.2. Cost Reduction and Data Integrity
9.3.1.3. Safe and Secure Transactions
9.3.1.4. Patient Data Management
9.3.2. Weaknesses
9.3.2.1. Implementation Expense
9.3.2.2. Storage
9.3.2.3. Immutability of Data
9.3.2.4. High Energy Consumption
9.3.3. Threats
9.3.3.1. Blockchain is Prone to Cyber Attacks
9.3.3.2. Scalability
9.3.3.3. Lack of Regulations Issued by Legal Authorities
9.3.4. Opportunities
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/blockchain-t You may also be interested in the following titles:
Cell Therapy Manufacturing Market
Global TCR Therapy Market
You may also like to learn what our experts are sharing in Roots educational series:
Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#blockchaintechnologyinhealthcaremarket #blockchaintechnologyinhealthcaremarketgrowth #blockchaintechnology #blockchain #blockchain industry
